Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China
Auto-generated profile, based on publicly available information
Min Yan
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China
Background. Tranexamic acid (TA) has emerged as a promising treatment for melasma without serious adverse effects. Ethosomes have been reported as the carriers for transdermal drug delivery systems to increase the amount of drug permeation through the skin. However, few studies of the local usage of TA‐loaded ethosomes exist. Objectives. To evaluate the efficacy of a mask containing 0.5% TA‐loaded ethosomes in the treatment of melasma in the Asian skin. Methods. In a double‐blind, placebo‐controlled, randomized, prospective study, 88 Asian participants with melasma were randomized 1 : 1 to two groups as follows: the TA or control. The TA group was treated with moisturizing masks with 0.5% TA‐loaded ethosomes, and the control was treated with moisturizing masks only. Masks were applied once daily for the first two weeks and once every other day for the third and fourth weeks. The primary outcome was measured by the modified melasma area and severity index (mMASI) and a visual analog scale (VAS) for vessels. The secondary outcomes were VAS for skin texture and satisfaction. Results. The reduction of VAS vessel scores at the end of treatment in the TA group was significantly greater than that in the control group (P < 0.001). The mMASI scores and skin texture scores decreased over time in both groups, but no significant differences were found between the two groups (P > 0.05). The score of participant satisfaction in the TA group was significantly higher than that in the control group (P < 0.01). Conclusions. Masks containing TA‐loaded ethosomes appear to be an effective treatment for Asian melasma in terms of angiogenesis and skin texture. It improves the pigmentation to some extent but has no significance. This trial is registered with ChiCTR1900024257.
Background and Objectives: Hand aging is complex, and while laser treatments effectively address pigmentation, their precise impact on skin thickness and wrinkles remains unclear. This study evaluates the effects of two 1064‐nm nanosecond laser modalities (Q‐switched Nd:YAG laser (Q‐NDY) and multidepth fractional laser (MDF)) on hand skin rejuvenation and safety. Materials and Methods: A randomized controlled trial involving 20 patients with hand aging signs was conducted. Participants were randomized to the Q‐NDY or MDF group, receiving three treatments at four‐week intervals, followed by a three‐month follow‐up. Outcomes were evaluated by two independent plastic surgeons using an observer‐reported scale. Skin physiology (thickness, melanin, and erythema indices) was measured, and patient satisfaction was assessed using the patient satisfaction scale (PSS). Results: Both modalities improved pigmentation and reduced wrinkles. The MDF group showed significantly greater improvement in fine wrinkles ( p = 0.0086) and skin texture ( p = 0.0209) and a significant increase in skin thickness ( p < 0.01), whereas the Q‐NDY group did not. Melanin and erythema indices decreased significantly by week 20, with a greater reduction in erythema in the MDF group ( p = 0.021). Overall satisfaction was 75% for Q‐NDY and 90% for MDF. Conclusion: Both 1064‐nm nanosecond laser modalities rejuvenate hand skin. The MDF mode showed superior outcomes in wrinkle reduction, skin texture, and thickness, offering a safe and effective treatment option for hand rejuvenation. Trial Registration: Chinese Registry of Clinical Trials: MR‐31‐23‐013044